DevCuration: the premier voice of the tech ecosystem, from ideation to enterprise
Live Deals
Element Biosciences Lands $175M Series E From Samsung as Genomics Infrastructure Heats Up$175M|Minerva Raises $20M to Build AI-Powered Consumer Intelligence for Marketers$20M|Cellares Raises Series D to $277M Series D as ARK Invest Bets on the Infrastructure Behind Cell Therapy$277M|Fearn Raises $5.5M Seed Round to Modernize Patent Drafting With AI$5.5M|Stars + Honey Raises $24M From VMG Partners to Scale National Protein Bar Expansion$24M|FesariusTherapeutics Raises $20M Series A as Regenerative Medicine Moves Toward Commercial Scale$20M|Orbital Raises $5M Pre-Seed to Build AI Data Centers in Low Earth Orbit$5M|Mesoware Raises $1.5M Pre-Seed to Tackle Manufacturing's Automation Reality Gap$1.5M|Pogo Raises $32M to Build an AI Consumer Research Platform on Verified Behavioral Data$32M|Standard Bots Raises $200M Series C as Physical AI Moves From Theory to Factory Floors$200M|GT Medical Technologies Raises $100M Series E as Brain Tumor Treatment Moves From Clinical Promise to Commercial Scale$100M|Element Biosciences Lands $175M Series E From Samsung as Genomics Infrastructure Heats Up$175M|Minerva Raises $20M to Build AI-Powered Consumer Intelligence for Marketers$20M|Cellares Raises Series D to $277M Series D as ARK Invest Bets on the Infrastructure Behind Cell Therapy$277M|Fearn Raises $5.5M Seed Round to Modernize Patent Drafting With AI$5.5M|Stars + Honey Raises $24M From VMG Partners to Scale National Protein Bar Expansion$24M|FesariusTherapeutics Raises $20M Series A as Regenerative Medicine Moves Toward Commercial Scale$20M|Orbital Raises $5M Pre-Seed to Build AI Data Centers in Low Earth Orbit$5M|Mesoware Raises $1.5M Pre-Seed to Tackle Manufacturing's Automation Reality Gap$1.5M|Pogo Raises $32M to Build an AI Consumer Research Platform on Verified Behavioral Data$32M|Standard Bots Raises $200M Series C as Physical AI Moves From Theory to Factory Floors$200M|GT Medical Technologies Raises $100M Series E as Brain Tumor Treatment Moves From Clinical Promise to Commercial Scale$100M
Where the Money Moved
Minerva Raises $20M to Build AI-Powered Consumer Intelligence for Marketers
Jun 11, 2026
Cellares Raises Series D to $277M Series D as ARK Invest Bets on the Infrastructure Behind Cell Therapy
Jun 11, 2026
Fearn Raises $5.5M Seed Round to Modernize Patent Drafting With AI
Jun 11, 2026
Stars + Honey Raises $24M From VMG Partners to Scale National Protein Bar Expansion
Jun 11, 2026
FesariusTherapeutics Raises $20M Series A as Regenerative Medicine Moves Toward Commercial Scale
Jun 11, 2026
Popular
01
Where the Money Moved
Element Biosciences Lands $175M Series E From Samsung as Genomics Infrastructure Heats Up
Jun 11, 202602
Where the Money Moved
Minerva Raises $20M to Build AI-Powered Consumer Intelligence for Marketers
Jun 11, 202603
Where the Money Moved
Cellares Raises Series D to $277M Series D as ARK Invest Bets on the Infrastructure Behind Cell Therapy
Jun 11, 202604
Where the Money Moved
Fearn Raises $5.5M Seed Round to Modernize Patent Drafting With AI
Jun 11, 202605
Where the Money Moved
Stars + Honey Raises $24M From VMG Partners to Scale National Protein Bar Expansion
Jun 11, 202606
Where the Money Moved
FesariusTherapeutics Raises $20M Series A as Regenerative Medicine Moves Toward Commercial Scale
Jun 11, 2026Live Feed
Where The Money Moved
News
More articles
Upcoming Events
More articles
Frameworks
More articles
The Provenance Problem — Why AI Governance Is Collapsing Into Proof of Human Control
Jesse LandryMar 26, 2026
The Velocity Trap
Jesse LandryFeb 19, 2026
Capital Timing, Not Capital Access: Why money is almost never the constraint and almost always the problem
Jesse LandryFeb 12, 2026